At what enterprise value was LABORATOIRES ANIOS acquired in 2013?

During the acquisition of LABORATOIRES ANIOS by ARDIAN in 2013, the transaction's Enterprise Value is estimated to be in the range of 300M - 700M EUR.

What was the EV/EBITDA of LABORATOIRES ANIOS when it was acquired by ARDIAN?

The estimated EV/EBITDA multiple for LABORATOIRES ANIOS is in the range of 5x - 12x.

When was LABORATOIRES ANIOS acquired by ARDIAN?

LABORATOIRES ANIOS was acquired by ARDIAN in 2013.

What was the revenue of LABORATOIRES ANIOS at the time of the deal?

The revenue of LABORATOIRES ANIOS at the time of the deal is estimated to be in the range of 100M - 200M EUR.

What was the EBITDA of LABORATOIRES ANIOS during the acquisition?

LABORATOIRES ANIOS's EBITDA is estimated to be in the range of 25M - 50M EUR.

How is the data for the LABORATOIRES ANIOS acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the LABORATOIRES ANIOS deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.ardian.com/fr/communiques-de-presse/ardian-et-bertrand-et-thierry-letartre-concluent-la-cession-des-laboratories

← DATABASE

Home Database Healthcare & PharmaLABORATOIRES ANIOS

10/2013

LABORATOIRES ANIOS acquired by ARDIAN

FRANCE Life Sciences / Medical Devices / Medical Consumables EV 300M - 700M EUR

Context

Air Liquide has entered into exclusive negotiations to sell its 66% majority stake in Laboratoires Anios to a consortium comprised of Ardian and the founding Letartre brothers, Bertrand and Thierry. This transaction represents a strategic spin-off for Air Liquide, allowing the industrial gas giant to refocus its hygiene activities exclusively on its German subsidiary, Schülke & Mayr. The acquisition is structured with an LBO featuring a senior debt facility and an important CAPEX line to fund future growth. The financing reflects a leverage effect of 4.0x to 5.0x EBITDA. The primary strategic rationale for the new ownership is to accelerate Anios's international footprint, particularly through M&A opportunities in emerging markets such as Brazil, India, and China, moving the company toward a more globalized operational model.

LABORATOIRES ANIOS, which reported an EBITDA margin of in 2012, is valued in this transaction at an EV/EBITDA multiple of , representing a to the average currently observed in the Healthcare & Pharma sector (14.5x).

-> Deep-dive in Healthcare & Pharma market trends

Target

Founded by the Letartre family and based in Lille, Laboratoires Anios is a European leader in the hygiene and disinfection sector for hospitals, clinics, and industrial environments. The company provides holistic solutions for medical device disinfection, including endoscope washer-disinfectors, as well as products for the food and professional cleaning industries. Its business model integrates high-intensity R&D with specialized chemical manufacturing across international sites.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2012

2011

Other operations with LABORATOIRES ANIOS

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
Date	Acquirer	Target	Country	Sector
02/2017	ECOLAB	LABORATOIRES ANIOS	FRANCE	Medical Consumables

REFERENCES

Valuation range: EV 300M - 700M EUR

Revenue range: 100M - 200M EUR

EBITDA range: 25M - 50M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of LABORATOIRES ANIOS by ARDIAN are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Press release: view release

Target: laboratoires anios

Acquirer: ardian